Free Access
Issue
J Extra Corpor Technol
Volume 42, Number 4, December 2010
Page(s) 286 - 292
DOI https://doi.org/10.1051/ject/201042286
Published online 15 December 2010
  1. Rizzi G, Scrivani A, Fini M, Giardino R. Biomedical coatings to improve the tissue-biomaterial interface. Int J Artif Organs. 2004;27:649–57. [CrossRef] [PubMed] [Google Scholar]
  2. von Segesser LK, Tozzi P, Mallbiabrrena I, Jegger D, Horisberger J, Corno A. Miniaturization in cardiopulmonary bypass. Perfusion. 2003;18:219–24. [CrossRef] [PubMed] [Google Scholar]
  3. Groom RC. A systematic approach to the understanding and redesigning of cardiopulmonary bypass. Semin Cardiothorac Vasc Anesth. 2005;9:159–61. [CrossRef] [PubMed] [Google Scholar]
  4. Norman MJ, Sistino JJ, Acsell JR. The effectiveness of low-prime cardiopulmonary bypass circuits at removing gaseous emboli. J Extra Corpor Technol. 2004;36:336–42. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Ovrum E, Tangen G, Oystese R, Ringdal MAL, Istad R. Comparison of two heparin coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. J Thorac Cardiovasc Surg. 2001;121:324–30. [CrossRef] [Google Scholar]
  6. Videm V, Mollnes TE, Fosse E, et al. Heparin coated cardiopulmonary bypass equipment: Biocompatibility markers and development of complications in a high risk population. J Thorac Cardiovasc Surg. 1999;117:794–802. [CrossRef] [Google Scholar]
  7. Gunaydin S, McCusker K, Vijay V. Clinical performance and biocompatibility of hyaluronan based heparin bonded extracorporeal circuits. J Extra Corpor Technol. 2005;37:290–5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  8. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15:816–23. [CrossRef] [Google Scholar]
  9. Repo H, Jansson SE, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods. 1993;164:193–202. [CrossRef] [PubMed] [Google Scholar]
  10. Tanaka M, Motomura T, Kawada M, et al. Blood compatible aspects of poly(2-methoxyethylacrylate) relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials. 2000;21:1471–81. [CrossRef] [PubMed] [Google Scholar]
  11. Gunaydin S, Farsak B, Mccusker K, et al. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. J Cardiovasc Med. (Hagerstown) 2009;10:135–42. [CrossRef] [PubMed] [Google Scholar]
  12. Gunaydin S, McCusker K, Sari T, Onur MA, Zorlutuna Y. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracoporeal circuits in different risk cohorts. Interact Cardiovasc Thorac Surg. 2010;10:371–6. [CrossRef] [PubMed] [Google Scholar]
  13. Zamora E, Delgado L, Castro MA, et al. Coronary artery bypass surgery using the mini-extracorporeal circulation system: A Spanish unit’s experience. Rev Esp Cardiol. 2008;61:376–81. [CrossRef] [Google Scholar]
  14. Moen O, Fosse E, Dregelid E, et al. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg. 1996;62:1134–40. [CrossRef] [Google Scholar]
  15. Nishida H, Aomi S, Tomizawa Y, et al. Comparative study of biocompatibility between open circuit and closed circuit in cardiopulmonary bypass. Artif Organs. 1999;23:547–51. [CrossRef] [PubMed] [Google Scholar]
  16. Gunaydin S, Sari T, McCusker K, Schonrock U, Zorlutuna Y. Clinical evaluation of minimized extracorporeal circulation in high-risk coronary revascularization: Impact on air handling, inflammation, hemodilution and myocardial function. Perfusion. 2009;24:153–62. [CrossRef] [PubMed] [Google Scholar]
  17. Gunaydin S, McCusker K, Vijay V. Clinical and biomaterial evaluation of a new condensed dual-function extracorporeal circuit in reoperation for coronary artery bypass surgery. Int J Artif Organs. 2009;32:802–10. [CrossRef] [PubMed] [Google Scholar]
  18. Casalino S, Stelian E, Novelli E, et al. Reduced transfusion requirements with a closed cardiopulmonary bypass system. J Cardiovasc Surg (Torino). 2008;49:363–9. [PubMed] [Google Scholar]
  19. Fukada J, Morishita K, Ingu A, et al. Comparative study of the effect on clinical outcome of the use of an open circuit and the use of a closed circuit in cardiopulmonary bypass for a graft replacement of the descending thoracic or thoracoabdominal aorta. Surg Today. 2004;34:11–5. [CrossRef] [PubMed] [Google Scholar]
  20. Nakahira A, Sasaki Y, Hirai H, et al. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2010;10:555–60. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.